ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New

MUSC Catalyst News, MUSC

Ananda Scientific (@AnandaScience) / X

A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions

ANANDA Scientific

Google Pilots Opioid Addiction Moonshot in Dayton, Ohio - Bloomberg

ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)

Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs - ScienceDirect

FDA approves IND for Ananda Scientific's PTSD treatment

ANANDA Scientific Announces First Patient Enrolled in the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

Articles about Ananda Scientific

Substance Abuse Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends